EGFR Inhibitors Market to Witness Upsurge in Growth at a CAGR of 7.9% During the Forecast Period (2026-2036) Owing to the Entry of Next-generation TKIs, ADCs, and Combination Strategies with Immunotherapy| DelveInsight

EGFR InhibitorsNext-generation TKIsADCsPositive

AI Analysis

Summary

DelveInsight market analysis forecasts EGFR inhibitors market to grow at 7.9% CAGR from 2026-2036, driven by next-generation TKIs, ADCs, and immunotherapy combination strategies.

Importance:2/10

Sentiment:

0.30

market analysisEGFR inhibitorsTKIADCimmunotherapy combinationforecast

Related Companies

$AVBP

Read the original article

Published by yahoo_finance on June 15, 2026 4:31 PM

Read Original